STARKS DANIEL J
SEC CIK 902132 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ABT | Abbott Laboratories | Dir | 6.75M | $2.01M | $31.93M | 13 | 2022-04-29 | 2026-04-27 |
Most active insiders at ABT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ford Robert B | COB AND CEO, Dir | $2.01M | $46.20M |
| 2 | STARKS DANIEL J | Dir | $2.01M | — |
| 3 | Morrone Louis H. | EVP | — | $774.7K |
| 4 | Shroff Eric | SVP | — | $285.0K |
| 5 | Boudreau Philip P | EVP AND CFO | $201.3K | — |
| 6 | Stratton John G | Dir | $173.6K | — |
| 7 | Salvadori Daniel Gesua Sive | EVP AND GROUP Pres | — | $102.3K |
| 8 | Moreland Mary K | EVP | — | $70.9K |
| 9 | MCCOY JOHN A. JR. | VP AND Ctrl | — | $70.6K |
| 10 | Cushman Elizabeth C. | EVP, GC AND Sec | — | $30.4K |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-28 19:37 | 2026-04-24 | ABT | Abbott Laboratories | STARKS DANIEL J | Dir | A - Grant | $0.00 | +2,286 | 6.74M | +0.0% | $0 |
| D | 2026-04-28 19:37 | 2026-04-27 | ABT | Abbott Laboratories | STARKS DANIEL J | Dir | P - Purchase | $92.65 | +10.0K | 6.75M | +0.1% | +$926.5K |
| M | 2026-02-06 | 2026-02-04 | ABT | Abbott Laboratories | STARKS DANIEL J | Dir | P - Purchase | $108.73 | +10.0K | 6.73M | +0.1% | +$1.09M |
| D | 2025-04-29 | 2025-04-25 | ABT | Abbott Laboratories | STARKS DANIEL J | Dir | A - Grant | $0.00 | +1,635 | 6.73M | +0.0% | $0 |
| D | 2024-04-30 | 2024-04-26 | ABT | Abbott Laboratories | STARKS DANIEL J | Dir | A - Grant | $0.00 | +1,866 | 6.73M | +0.0% | $0 |
| M | 2023-10-30 | 2023-10-26 | ABT | Abbott Laboratories | STARKS DANIEL J | Dir | S - Sale | $94.05 | -50.0K | 6.73M | -0.7% | -$4.70M |
| M | 2023-07-28 | 2023-07-27 | ABT | Abbott Laboratories | STARKS DANIEL J | Dir | S - Sale | $113.77 | -50.0K | 6.80M | -0.7% | -$5.69M |
| D | 2023-05-02 | 2023-04-28 | ABT | Abbott Laboratories | STARKS DANIEL J | Dir | A - Grant | $0.00 | +1,816 | 6.88M | +0.0% | $0 |
| DM | 2023-05-02 | 2023-05-02 | ABT | Abbott Laboratories | STARKS DANIEL J | Dir | S - Sale | $111.02 | -50.0K | 6.83M | -0.7% | -$5.55M |
| M | 2022-10-31 | 2022-10-27 | ABT | Abbott Laboratories | STARKS DANIEL J | Dir | S - Sale | $97.46 | -50.0K | 6.88M | -0.7% | -$4.87M |
| M | 2022-07-28 | 2022-07-26 | ABT | Abbott Laboratories | STARKS DANIEL J | Dir | S - Sale | $109.14 | -50.0K | 6.95M | -0.7% | -$5.46M |
| M | 2022-05-05 | 2022-05-03 | ABT | Abbott Laboratories | STARKS DANIEL J | Dir | S - Sale | $113.22 | -50.0K | 7.01M | -0.7% | -$5.66M |
| 2022-05-03 | 2022-04-29 | ABT | Abbott Laboratories | STARKS DANIEL J | Dir | A - Grant | $0.00 | +1,602 | 7.02M | +0.0% | $0 |
Purchase Sale Sale after option exercise All abbreviations